Related Experiment Videos
Thymic carcinoids in multiple endocrine neoplasia type 1
1Department of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden. bin.teh@cmm.ki.se
Journal of Internal Medicine
|July 29, 1998
Summary
Thymic carcinoid, a rare cancer linked to Multiple Endocrine Neoplasia type 1 (MEN-1), often invades locally and metastasizes. Early chest imaging and prophylactic thymectomy are recommended for MEN-1 patients.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Thymic carcinoid is a rare neuroendocrine tumor with approximately 150 reported cases.
- It is associated with Multiple Endocrine Neoplasia type 1 (MEN-1), yet remains poorly understood compared to other MEN-1 related neoplasias.
Purpose of the Study:
- To investigate the characteristics and clinical implications of MEN-1-related thymic carcinoid.
- To propose improved diagnostic and prophylactic strategies for MEN-1 patients at risk.
Main Methods:
- Analysis of 20 MEN-1-related thymic carcinoid cases.
- Review of existing literature on thymic carcinoid and MEN-1 associations.
- Genetic analysis including loss of heterozygosity (LOH) in the MEN1 region and MEN1 mutations.
Main Results:
- MEN-1 related cases constitute up to 25% of all reported thymic carcinoids.
- The tumor is insidious, lacking typical carcinoid or Cushing's syndrome symptoms, but exhibits frequent local invasion, recurrence, and metastasis.
- Genetic findings suggest additional etiological factors beyond MEN1 mutations, including male predominance and familial clustering.
Conclusions:
- Routine chest imaging (CT or MRI) should be incorporated into the clinical workup for all MEN-1 patients.
- Consideration of prophylactic thymectomy during parathyroid surgery in MEN-1 patients may reduce malignancy risk.